Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
---|---|---|---|---|---|---|
2019 | Hyperactive CREB signaling pathway involved in the pathogenesis of polycystic ovarian syndrome revealed by patient-specific induced pluripotent stem cell modeling. | Huang, CC; Chen, MJ; Lan, CW; Wu, CE; Huang, MC; Kuo, HC ; Ho, HN | FERTILITY AND STERILITY 112(3), 594-607.e12 | |||
2020 | PRKDC: A New Biomarker and drug target for Checkpoint Blockade Immunotherapy | Tan, KT; Yeh, CN; Chang, YC; Cheng, JH; Fang, WL; Yeh, YC; Hsu, DS; Wu, CE; Liu, CY; Chang, MS; Lu, ML; Chen, SJ; Yee, C; Hsiao, M ; Chen, MH | Journal for ImmunoTherapy of Cancer 8(1), e000485 | |||
2021 | Ruxolitinib Combined with Gemcitabine against Cholangiocarcinoma Growth via the JAK2/STAT1/3/ALDH1A3 Pathway | Chung, SY; Hung, YP; Pan, YR; Chang, YC; Wu, CE; Hsu, DS; Chang, PM; Lu, ML; Huang, CY; Su, Y; Hsiao, M ; Yeh, CN; Chen, MH | BIOMEDICINES 9(8), 885 |